Clinicopathologic characteristics of placental site trophoblastic tumors

Objective: This study was aimed at analyzing the clinicopathological features and treatment of patients with placental site trophoblastic tumor (PSTT) in Shanghai, China, and to investigate high-risk factors for metastasis and relapse. Methods: Thirteen patients with placental site trophoblastic tumors who received treatment in the Obstetrics and Gynecology Hospital Affiliated with Fudan University in Shanghai, China, between Jan 2002 and July 2014 were reviewed. The cases were divided into two groups: confined and non-confined (CG and NCG, respectively). CG included patients in stage I without evidence of recurrence during the follow-up, whereas NCG included advanced stage or stage I with recurrent lesions. The clinical data, treatment and prognosis were collected from medical records. Results: The median age of the patients with placental site trophoblastic tumors was approximately 30.1 years. Gravidity ranged from 1 to 4 pregnancies. Antecedent pregnancies included term deliveries, abortions and complete molar pregnancies. The average time interval from antecedent pregnancy was 7.7 months. Irregular vaginal bleeding was the most common presentation. Most patients had a plasma hCG level less than 500 mIU/ml. All patients received either laparoscopically assisted vaginal hysterectomy or total abdominal hysterectomy. Patients in the NCG group were treated with combined chemotherapy such as EMA-CO or EP-EMA to achieve remission. No difference was observed in the expression of hPL, inhibin-α, p53 or the Ki-67 labeling index between the CG and NCG groups. However, there were statistically significant differences of age (≥ 35 years), gravidity (> 2), tumor size (≥ 30 mm) and myometrial invasion depth (≥ 1/2) in the NCG group (P = 0.002, 0.002, 0.015 and 0.024, respectively). Conclusions: This study showed that patient age, gravidity, tumor size and myometrial invasion depth might be predictors for metastasis and recurrence of PSTT. Surgery and combined chemotherapy are suggested in patients with those high-risk factors.

[1]  Jun Zhao,et al.  Fertility-Preserving Treatment in Young Patients With Placental Site Trophoblastic Tumors , 2012, International Journal of Gynecologic Cancer.

[2]  L. Horn,et al.  [Histopathology of gestational trophoblastic disease. An update]. , 2009, Der Pathologe.

[3]  T. Jobo,et al.  Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases. , 2007, Gynecologic oncology.

[4]  R. Berkowitz,et al.  Gestational Trophoblastic Disease , 1998, Clinical obstetrics and gynecology.

[5]  Jun Zhao,et al.  Clinical and pathologic characteristics and prognosis of placental site trophoblastic tumor. , 2006, Journal of reproductive medicine.

[6]  R. Scully,et al.  Placental site trophoblastic tumor : A study of 55 cases and review of the literature emphasizing factors of prognostic significance , 2006 .

[7]  Ycr Academic.  Placental site trophoblastic tumour: Clinical features and management , 2006 .

[8]  D. Mutch,et al.  Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. , 2004, Gynecologic oncology.

[9]  J. Lurain,et al.  Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment. , 2004, The Journal of reproductive medicine.

[10]  E. Abraham,et al.  Placental Site Trophoblastic Tumor , 2003, Obstetrical & gynecological survey.

[11]  I. McNeish,et al.  Twenty-five years' clinical experience with placental site trophoblastic tumors. , 2002, The Journal of reproductive medicine.

[12]  R. Berkowitz,et al.  Advances in the understanding of placental site trophoblastic tumor. , 2002, The Journal of reproductive medicine.

[13]  I. Shih,et al.  Molecular basis of gestational trophoblastic diseases. , 2002, Current molecular medicine.

[14]  R. Berkowitz,et al.  Placental site Trophoblastic tumor: A 17-year experience at the New England Trophoblastic Disease Center , 2002 .

[15]  I. Shih,et al.  Placental site trophoblastic tumor--past as prologue. , 2001, Gynecologic oncology.

[16]  I. Shih,et al.  The pathology of intermediate trophoblastic tumors and tumor-like lesions. , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[17]  R. Coleman,et al.  Placental site trophoblastic tumour: a rare but potentially curable cancer , 2000, British Journal of Cancer.

[18]  Y. Soong,et al.  Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. , 1999, Gynecologic oncology.

[19]  H. Frierson,et al.  Detection of the alpha-subunit of inhibin in trophoblastic neoplasia. , 1999, Human pathology.

[20]  L. Twiggs,et al.  Trophoblastic pseudotumor-evidence of malignant disease potential. , 1981, Gynecologic oncology.

[21]  R. Scully,et al.  Trophoblastic pseudotumor: a reappraisal. , 1981, The American journal of surgical pathology.

[22]  R. Scully,et al.  Trophoblastic pseudotumor of the uterus. An exaggerated form of “syncytial endometritis” simulating a malignant tumor , 1976, Cancer.